These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 10254882)
1. The P&T Committee and cancer chemotherapy: Part II. Who should prescribe anticancer drugs. Krakoff IH Hosp Formul; 1982 Apr; 17(4):577-8. PubMed ID: 10254882 [No Abstract] [Full Text] [Related]
2. Editors' roundtable: current formulas for P & T Committee success. (Part 2). Lipman AG; Neu HC; Singh BN; Weintraub M Hosp Formul; 1987 Apr; 22(4):373-82. PubMed ID: 10281367 [TBL] [Abstract][Full Text] [Related]
3. Drug utilization reviews--a major responsibility of the P&T committee: an administrative overview. Godwin HN Hosp Formul; 1981 Jun; 16(6):609, 613-5. PubMed ID: 10251441 [No Abstract] [Full Text] [Related]
4. The P&T committee and drug use review. Provost GP Hosp Formul; 1979 May; 14(5):596, 594. PubMed ID: 10242199 [No Abstract] [Full Text] [Related]
5. Making your P & T Committee work for you. Lipman AG Hosp Formul; 1987 Jan; 22(1):103-4. PubMed ID: 10311841 [No Abstract] [Full Text] [Related]
17. Does your committee pass the McNemar test? Owen JA Hosp Formul; 1979 Jun; 14(6):605. PubMed ID: 10242200 [No Abstract] [Full Text] [Related]
18. Adverse drug reactions and the P & T committee. Lipman AG Hosp Formul; 1980 Jul; 15(7):580. PubMed ID: 10247654 [No Abstract] [Full Text] [Related]
19. What guidelines should a P & T Committee consider for the handling of cytotoxic drugs? Mofenson HC; Caraccio TR Hosp Formul; 1988 Nov; 23(11):923-4. PubMed ID: 10290755 [No Abstract] [Full Text] [Related]
20. [Drug committees towards the regions. The Danish Society of Clinical Pharmacology]. Reuther LØ; Brock B; Ugeskr Laeger; 2007 Mar; 169(12):1113. PubMed ID: 17394824 [No Abstract] [Full Text] [Related] [Next] [New Search]